日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.

TRC105 抗内皮糖蛋白 (CD105) 抗体治疗转移性去势抵抗性前列腺癌的 I 期研究

Karzai Fatima H, Apolo Andrea B, Cao Liang, Madan Ravi A, Adelberg David E, Parnes Howard, McLeod David G, Harold Nancy, Peer Cody, Yu Yunkai, Tomita Yusuke, Lee Min-Jung, Lee Sunmin, Trepel Jane B, Gulley James L, Figg William D, Dahut William L

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer

CYP2C8基因中的单核苷酸多态性与去势抵抗性前列腺癌男性患者发生双膦酸盐相关性颌骨坏死无关

English, Bevin C; Baum, Caitlin E; Adelberg, David E; Sissung, Tristan M; Kluetz, Paul G; Dahut, William L; Price, Douglas K; Figg, William D